Clinical Trial for Experimental Covid-19 Vaccine Begins

0 756

Scientists at the Kaiser Permanente Research Institute in Seattle, Washington applied the world’s first experimental vaccine for Coronavirus.

It is the first phase of a study for a possible vaccine against the virus that causes COVID-19 which is wreaking havoc worldwide.

A total of 45 healthy volunteers will receive the vaccine – two doses with a month in between. This is the first step to find out if the vaccines are safe and effective, and possibly make way for possible global distribution.

To date, the pandemic has infected more than 169,000 people and killed more than 6,500 worldwide.

HOLA AMIGOS! Have questions or comments for PRESENTE? Send them to admin@presentepgh.com.

Covid19
Keep up with all our posts!
Advertise with PresentePGH

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from Pittsburgh Latino Magazine

Subscribe now to keep reading and get access to the full archive.

Continue reading